METX — ME Therapeutics Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for ME Therapeutics Holdings, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.

	2020 August 31st	2021 August 31st	2022 August 31st	2023 August 31st	2024 August 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.05	0.073	0.077	0.647	1.5
Net Total Receivables	0.02	0.002	0.023	0.007	0.017
Prepaid Expenses
Total Current Assets	0.07	0.075	0.102	0.672	1.54
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0	0	0	0
Net Intangible Assets
Total Assets	0.07	0.075	0.102	0.672	1.54
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.006	0.033	0.174	0.148	0.063
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.046	0.093	0.234	0.148	0.063
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.024	-0.018	-0.131	0.523	1.48
Total Liabilities & Shareholders' Equity	0.07	0.075	0.102	0.672	1.54
Total Common Shares Outstanding